Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data

BACKGROUND: Treatment of stable chronic obstructive pulmonary disease (COPD) with long-acting bronchodilator (LABD) medications is recommended by the 2014 Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines. The primary objective of this study was to examine LABD prescription fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Christine L, Zou, Kelly H, Su, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014371/
https://www.ncbi.nlm.nih.gov/pubmed/24833898
http://dx.doi.org/10.2147/COPD.S59322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014371/
https://www.ncbi.nlm.nih.gov/pubmed/24833898
http://dx.doi.org/10.2147/COPD.S59322

Ejemplares similares